Dolby Laboratories (DLB) Stock

About Dolby Laboratories

Dolby Laboratories (DLB) stock trades at $62.85 with a market capitalization of $5.89B. The stock is valued at a price-to-earnings (P/E) ratio of 24.61, price-to-book of 2.14, price-to-sales of 4.11. Over the past 52 weeks the stock has ranged between $48.26 and $73.01, and currently trades 13.9% below its 52-week high. It pays a dividend yielding 2.46%.

On profitability, Dolby Laboratories generates a return on equity (ROE) of 8.68%, return on capital employed of 8.95%, an operating margin of 19.64%, a net profit margin of 16.70%.

Dolby Laboratories by the numbers, 2016–2025

Between 2016 and 2025 Dolby Laboratories reported revenue of $1.0B rising to $1.3B, a change of +31.5% across 10 years. Compounded, revenue has grown 3.0% a year over five years, 2.5% over three, 5.9% over the last twelve months. Net profit rose to $255.0M.

Operating margin went from 22.7% in 2016 to 19.6% in 2025, a fall of 3.1 percentage points. The most recent net margin is 16.70%. On a trailing twelve-month basis to Jun '26, revenue is $1.4B and net profit $226.0M.

Borrowings stand at $39.0M, cash from operations was $472.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 9.8% over five years, and was 9.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Dolby Laboratories (DLB) — frequently asked questions